NCT06865950 Sex diffErences in prehoSpitAl Stroke MEdicine
| NCT ID | NCT06865950 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universität des Saarlandes |
| Condition | Stroke Acute |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2025-05-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: Stroke is a leading cause for individual, family and societal harm with huge health-economic impact. Immediate and correct prehospital acute stroke pathway initiation is key for treatment success. Evidence points towards sex inequity in management pathways of acute stroke care. A complicating factor in acute stroke management is the diversity in clinical presentation among patients of different sex. This increases the challenges of correct prehospital identification. Most of the currently available data on male and female differences in acute stroke management come from patients with hospital-confirmed stroke. Little to no information is available about sex-related management differences of patients with prehospital suspected stroke, often missed by stroke quality databases. Objectives: To identify sex differences in EMS-delivered prehospital diagnostic accuracy and management of patients with suspected or confirmed acute stroke. Methods: International project collaboration to conduct a cross-regional cohort analysis of patients with a prehospital working diagnosis of stroke and/or hospital-confirmed stroke diagnosis. Relevance: More information and details about the reasons for a potential prehospital treatment inequity are a necessary next step for any improvement and subsequent development of structured training programmes for emergency medical service personnel. This project is the first large-scaled international collaboration addressing sex differences in prehospital stroke care. With this approach the project will not only lead to more urgently needed information, but will also serve as a lighthouse project for raising general awareness for this topic.
Eligibility Criteria
Inclusion Criteria: * For all participants: * Adults aged 18 years of age and older * Emergency call to the national emergency telephone number because of acute symptoms * EMS treatment For cohort 1: \- Working diagnosis of acute stroke or TIA raised by the emergency medical dispatch centre For cohort 2: \- Working diagnosis of acute stroke or TIA raised by the EMS personnel at the emergency site For cohort 3: \- Hospital confirmed diagnosis of acute stroke or TIA Exclusion Criteria: * Patients, who have acute stroke symptoms but do not involve the EMS and make their way to hospital themselves
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06865950 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06865950 currently recruiting?
Yes, NCT06865950 is actively recruiting participants. Contact the research team at silke.walter@uks.eu for enrollment information.
Where is the NCT06865950 trial being conducted?
This trial is being conducted at Homburg, Germany.
Who is sponsoring the NCT06865950 clinical trial?
NCT06865950 is sponsored by Universität des Saarlandes. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.